Cargando…

A Carbonic Anhydrase IX/SLC1A5 Axis Regulates Glutamine Metabolism Dependent Ferroptosis in Hypoxic Tumor Cells

The ability of tumor cells to alter their metabolism to support survival and growth presents a challenge to effectively treat cancers. Carbonic anhydrase IX (CAIX) is a hypoxia-induced, metabolic enzyme that plays a crucial role in pH regulation in tumor cells. Recently, through a synthetic lethal s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venkateswaran, Geetha, McDonald, Paul C., Chafe, Shawn C., Brown, Wells S., Gerbec, Zachary J., Awrey, Shannon J., Parker, Seth J., Dedhar, Shoukat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Targeting Drug Resistance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543979/ https://www.ncbi.nlm.nih.gov/pubmed/37348875 http://dx.doi.org/10.1158/1535-7163.MCT-23-0041

Ejemplares similares

Interplay of Carbonic Anhydrase IX With Amino Acid and Acid/Base Transporters in the Hypoxic Tumor Microenvironment
por: Venkateswaran, Geetha, et al.
Publicado: (2020)

Carving out its niche: A role for carbonic anhydrase IX in pre-metastatic niche development
por: Chafe, Shawn C, et al.
Publicado: (2015)

Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside
por: McDonald, Paul C., et al.
Publicado: (2022)

Bcl-xL Is a Key Mediator of Apoptosis Following KRAS(G12C) Inhibition in KRAS(G12C)-mutant Colorectal Cancer
por: Khawaja, Hajrah, et al.
Publicado: (2023)

HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models
por: Gómez, Valentí, et al.
Publicado: (2022)

Optimal Strategy and Benefit of Pulsed Therapy Depend On Tumor Heterogeneity and Aggressiveness at Time of Treatment Initiation
por: Mathur, Deepti, et al.
Publicado: (2022)

Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-X(L)–Specific Degrader DT2216
por: Thummuri, Dinesh, et al.
Publicado: (2022)

Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer
por: Gopinathan, Ganga, et al.
Publicado: (2022)

Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes
por: Coker, Elizabeth A., et al.
Publicado: (2022)

NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
por: Llaurado Fernandez, Marta, et al.
Publicado: (2022)

Coordinated Regulation of Metabolic Transporters and Migration/Invasion by Carbonic Anhydrase IX
por: McDonald, Paul C., et al.
Publicado: (2018)

Harnessing Induced Essentiality: Targeting Carbonic Anhydrase IX and Angiogenesis Reduces Lung Metastasis of Triple Negative Breast Cancer Xenografts
por: Hedlund, Eva-Maria E., et al.
Publicado: (2019)

Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
por: McDonald, Paul C., et al.
Publicado: (2012)

Granulocyte Colony Stimulating Factor Expression in Breast Cancer and Its Association with Carbonic Anhydrase IX and Immune Checkpoints
por: Chafe, Shawn C., et al.
Publicado: (2021)

A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
por: McDonald, Paul C., et al.
Publicado: (2020)

Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors
por: Chafe, Shawn C., et al.
Publicado: (2021)

Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction
por: McDonald, Paul C., et al.
Publicado: (2016)

The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion
por: Swayampakula, M, et al.
Publicado: (2017)

Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX
por: Lenferink, Anne E.G., et al.
Publicado: (2021)

Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer
por: Brown, Wells S., et al.
Publicado: (2020)

Novel therapeutic targets for amyotrophic lateral sclerosis
por: Batra, Gitika, et al.
Publicado: (2019)

Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents
por: Lougheed, Kathryn E.A., et al.
Publicado: (2011)

Serial image analysis of Mycobacterium tuberculosis colony growth reveals a persistent subpopulation in sputum during treatment of pulmonary TB
por: Barr, David A., et al.
Publicado: (2016)

Detection and characterization of drug-resistant conferring genes in Mycobacterium tuberculosis complex strains: A prospective study in two distant regions of Ghana
por: Otchere, I.D., et al.
Publicado: (2016)

Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer
por: Zhang, Chen, et al.
Publicado: (2023)

Syntaxin4-Munc18c Interaction Promotes Breast Tumor Invasion and Metastasis by Regulating MT1-MMP Trafficking
por: Brasher, Megan I., et al.
Publicado: (2022)

Targeting hypoxic tumour cells to overcome metastasis
por: Bennewith, Kevin L, et al.
Publicado: (2011)

The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
por: Andreucci, Elena, et al.
Publicado: (2018)

SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration
por: Eloranta, Katja, et al.
Publicado: (2023)

Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours
por: Ahlskog, J K J, et al.
Publicado: (2009)

Molecular Targeting of Carbonic Anhydrase IX in Mice with Hypoxic HT29 Colorectal Tumor Xenografts
por: Carlin, Sean, et al.
Publicado: (2010)

Expression of Hypoxic Marker Carbonic Anhydrase IX Predicts Poor Prognosis in Resectable Hepatocellular Carcinoma
por: Huang, Wei-Ju, et al.
Publicado: (2015)

Indirect Decompression Failure After Lateral Lumbar Interbody Fusion—Reported Failures and Predictive Factors: Systematic Review
por: Kirnaz, Sertac, et al.
Publicado: (2020)

Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects
por: Urooj, Tabinda, et al.
Publicado: (2020)

PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?
por: Aruleba, Raphael Taiwo, et al.
Publicado: (2019)

Binding of Carbonic Anhydrase IX to 45S rDNA Genes Is Prevented by Exportin-1 in Hypoxic Cells
por: Sasso, Emanuele, et al.
Publicado: (2015)

PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX
por: Mondal, Utpal K., et al.
Publicado: (2021)

Targeting hypoxic response for cancer therapy
por: Paolicchi, Elisa, et al.
Publicado: (2016)

Carbonic Anhydrases II, IX, and XII in Reflux Esophagitis
por: Nortunen, Minna, et al.
Publicado: (2021)

Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII
por: Al-Warhi, Tarfah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r9lrhvuvtge1e2tqh0jh96mik1